Abiratas 250mg Tablet

Abiratas 250mg Tablet Specification

Dosage Form
Oral tablet

Salt Composition
Abiraterone acetate

Origin
India

Enzyme Types
Other

Feature
Other

Ingredients
Other

Application
Other

Physical Color/Texture
Other

Fermentation Smell
Normal Smell

Storage Instructions
Store at normal temperature

Abiratas 250mg Tablet Trade Information

Minimum Order Quantity
5 Pieces

Payment Terms
Cash in Advance (CID)

Supply Ability
40 Pieces Per Week

Delivery Time
4 Days

Sample Policy
Contact us for information regarding our sample policy

Main Domestic Market
All India, South India

About Abiratas 250mg Tablet

Abiratas 250mg Tablet is an anti-cancer medication containing Abiraterone acetate, primarily used to treat metastatic castration-resistant prostate cancer (mCRPC). It belongs to the class of drugs called androgen biosynthesis inhibitors, which work by blocking the production of androgens (male hormones like testosterone) that fuel the growth of prostate cancer cells.

Since many drugs can interact, let your doctor know if you have high blood pressure, heart problems, liver problems, renal problems, or are receiving treatment for an infection. During treatment, it is recommended to use effective contraception, and frequent blood glucose checks may be required.

Brand Name: Abiratas

Composition: Abiraterone acetate

Mechanism of Action:

It inhibits the CYP17A1 enzyme, which is crucial for androgen (testosterone) production in the adrenal glands, testes, and prostate tumor tissues. By blocking this enzyme, it significantly reduces androgen levels, depriving prostate cancer cells of the hormones they need to grow. This is particularly effective in treating metastatic castration-resistant prostate cancer (mCRPC).

Uses:

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Metastatic High-Risk Castration-Sensitive Prostate Cancer (mCSPC)

Side Effects:

Swelling

Hypokalemia (low potassium)

Hypertension (high blood pressure)

Elevated liver enzymes

Fatigue

Joint pain

Nausea

Vomiting

Anemia

Diarrhea

Effective Prostate Cancer Management

Abiratas 250mg Tablet offers a targeted approach to managing prostate cancer. By inhibiting specific enzymes, the tablet works to reduce androgen production, thereby slowing the progression of cancer. Patients benefit from consistent oral dosage and reliable results under healthcare supervision.

Trusted Indian Manufacture and Supply

Produced and supplied by respected Indian suppliers and traders, Abiratas 250mg Tablet adheres to strict manufacturing standards. Its origin guarantees availability and quality, meeting both domestic and international pharmaceutical requirements.

FAQs of Abiratas 250mg Tablet:

Q: How should Abiratas 250mg Tablet be stored to ensure its effectiveness?

A: Abiratas 250mg Tablet should be stored at normal room temperature, away from excessive humidity and direct sunlight, to preserve its efficacy and safety.

Q: What is the main benefit of using Abiratas 250mg Tablet?

A: The primary benefit is its role in inhibiting enzymes involved in androgen production, which helps slow the progression of prostate cancer when used as part of prescribed therapy.

Q: When is Abiratas 250mg Tablet typically prescribed?

A: This tablet is commonly prescribed during advanced stages of prostate cancer, especially when other treatments have proven ineffective or when combination therapy is recommended.

Q: Where is Abiratas 250mg Tablet manufactured?

A: Abiratas 250mg Tablet is manufactured in India by qualified pharmaceutical suppliers and traders, ensuring compliance with quality standards.

Q: What is the process of taking Abiratas 250mg Tablet?

A: Abiratas 250mg Tablet is taken orally, usually once daily, as directed by a healthcare professional. Dosage may vary depending on individual treatment plans.